Published in Int J Tuberc Lung Dis on May 01, 2006
Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg (2009) 2.30
Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death. Int J Tuberc Lung Dis (2012) 1.58
Factors associated with mortality in patients with tuberculosis. BMC Infect Dis (2010) 1.39
Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis (2011) 1.38
Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis (2009) 1.33
Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003. Int J Tuberc Lung Dis (2011) 1.12
Personal and societal health quality lost to tuberculosis. PLoS One (2009) 1.12
Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health (2009) 1.10
Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors. BMC Infect Dis (2010) 1.07
HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons. AIDS Patient Care STDS (2009) 1.01
Predictors of death among patients who completed tuberculosis treatment: a population-based cohort study. PLoS One (2011) 1.01
Factors associated with mortality in tuberculosis patients. J Res Med Sci (2013) 0.97
HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health (2010) 0.94
Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis (2014) 0.94
Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational study. PLoS One (2011) 0.93
Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana. Int J Tuberc Lung Dis (2012) 0.92
Educational inequalities in tuberculosis mortality in sixteen European populations. Int J Tuberc Lung Dis (2011) 0.91
Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors. PLoS One (2015) 0.90
Death with tuberculosis in california, 1994-2008. Open Forum Infect Dis (2014) 0.90
Alcohol use and clinical manifestations of tuberculosis. J Infect (2008) 0.89
Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012. Ann Epidemiol (2014) 0.87
Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study. Br J Cancer (2013) 0.87
Alcohol use and clinical manifestations of tuberculosis. J Infect (2009) 0.85
Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol (2011) 0.84
Tuberculosis and excess alcohol use in the United States, 1997-2012. Int J Tuberc Lung Dis (2015) 0.80
Comparing the factors correlated with tuberculosis-specific and non-tuberculosis-specific deaths in different age groups among tuberculosis-related deaths in Taiwan. PLoS One (2015) 0.80
Factors Affecting Mortality and Treatment Completion of Tuberculosis Patients in Isfahan Province from 2006 to 2011. Int J Prev Med (2015) 0.77
Unemployment in TB patients - ten-year observation at regional center of pulmonology in Bydgoszcz, Poland. Med Sci Monit (2014) 0.77
Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment. PLoS One (2016) 0.75
Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore) (2016) 0.75
Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013. Public Health Rep (2017) 0.75
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
ENZYME INDUCTION AS AN ALL-OR-NONE PHENOMENON. Proc Natl Acad Sci U S A (1957) 14.34
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68
Making memories: brain activity that predicts how well visual experience will be remembered. Science (1998) 10.73
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med (1993) 8.49
Deaths due to medical errors are exaggerated in Institute of Medicine report. JAMA (2000) 7.05
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health (1987) 5.06
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis (2005) 4.36
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis (1987) 4.11
Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med (1994) 4.04
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med (1991) 3.64
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med (2009) 3.57
Routine prenatal screening for HIV infection. Lancet (1991) 3.43
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 3.37
Polarity of T cell shape, motility, and sensitivity to antigen. Immunity (1996) 3.33
The effects of local review on informed consent documents from a multicenter clinical trials consortium. Control Clin Trials (2003) 3.30
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
High-throughput in vivo analysis of gene expression in Caenorhabditis elegans. PLoS Biol (2007) 3.22
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) (2004) 3.07
A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02
Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis (2006) 2.97
Rostrolateral prefrontal cortex involvement in relational integration during reasoning. Neuroimage (2001) 2.91
Event-related activation in the human amygdala associates with later memory for individual emotional experience. J Neurosci (2000) 2.85
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Gate-tuning of graphene plasmons revealed by infrared nano-imaging. Nature (2012) 2.75
Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol (2001) 2.74
Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS (1999) 2.73
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Global patterns of human DNA sequence variation in a 10-kb region on chromosome 1. Mol Biol Evol (2001) 2.64
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses (2004) 2.64
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology (2004) 2.63
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet (1999) 2.62
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med (2003) 2.56
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
Errors in the treatment of tuberculosis in Baltimore. Chest (2000) 2.46
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis. Int J Tuberc Lung Dis (2005) 2.40
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. Am J Respir Crit Care Med (2004) 2.40
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis (2005) 2.34
Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis (1997) 2.31
Inhaled budesonide therapy for patients with stable COPD. Chest (1995) 2.31
Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.29
Eleven years of community-based directly observed therapy for tuberculosis. JAMA (1995) 2.27
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr (2015) 2.26
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA (2000) 2.25
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Integration of diverse information in working memory within the frontal lobe. Nat Neurosci (2000) 2.20
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis (1999) 2.18
Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis (2005) 2.16
Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol (2003) 2.14
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med (1996) 2.14
Deformation tensor morphometry of semantic dementia with quantitative validation. Neuroimage (2004) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance. Int J Tuberc Lung Dis (2014) 2.08
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation (1978) 2.05
Incidence of salmonellosis in patients with AIDS. J Infect Dis (1987) 2.04
An fMRI study of personality influences on brain reactivity to emotional stimuli. Behav Neurosci (2001) 2.03
A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J Biol Chem (1993) 2.02
Mycobacteria and AIDS mortality. Am Rev Respir Dis (1989) 2.02
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 2.01
Adolescent physical abuse: risk for adolescent psychiatric disorders. Am J Psychiatry (1998) 2.00
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (2001) 1.98
Impaired action knowledge in amyotrophic lateral sclerosis. Neurology (2008) 1.97
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med (2004) 1.96
Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development (2001) 1.95
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia (2006) 1.90
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med (1994) 1.87
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Am J Respir Crit Care Med (2015) 1.86
P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol (2001) 1.86
Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Am J Respir Crit Care Med (2005) 1.85
Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab (1997) 1.85
Construction and applications of DNA probes for detection of polychlorinated biphenyl-degrading genotypes in toxic organic-contaminated soil environments. Appl Environ Microbiol (1990) 1.80
Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology (2005) 1.79
Paradoxical worsening of tuberculosis in HIV-infected persons. Chest (2001) 1.78
E-mail versus conventional postal mail survey of geriatric chiefs. Gerontologist (2001) 1.78
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol (1994) 1.77